Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease

被引:10
|
作者
Babulal, Ganesh M. [1 ,2 ,3 ,4 ]
Chen, Ling [5 ]
Doherty, Jason M. [1 ]
Murphy, Samantha A. [1 ]
Johnson, Ann M. [6 ]
Roe, Catherine M. [1 ]
机构
[1] Washington Univ, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Inst Publ Hlth, St Louis, MO 63110 USA
[3] Univ Johannesburg, Fac Humanities, Dept Psychol, Johannesburg, South Africa
[4] George Washington Univ, Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC 20052 USA
[5] Washington Univ, Div Biostat, St Louis, MO 63110 USA
[6] Washington Univ, Ctr Clin Studies, St Louis, MO 63110 USA
关键词
Alzheimer's disease; anger; anxiety; biomarkers; cerebrospinal fluid; older adults; MILD BEHAVIORAL IMPAIRMENT; COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; OLDER-ADULTS; DEMENTIA; TAU; NEURODEGENERATION; PREVALENCE; PROFILE; DECLINE;
D O I
10.3233/JAD-215708
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) studies in cognitively normal (CN) older adults age >= 65 suggest depression is associated with molecular biomarkers (imaging and cerebrospinal fluid [CSF]). This study used linear mixed models (covariance pattern model) to assess whether baseline CSF biomarkers (A beta(42)/A beta(40), t-Tau/A beta(42) , p-Tau/A beta(42)) predicted changes in non-depressed mood states in CN older adults (N= 248), with an average of three follow-up years. Participants with higher levels of CSF biomarkers developed more anger, anxiety, and fatigue over time compared to those with more normal levels. Non-depressed mood states in preclinical AD may be a prodrome for neuropsychiatric symptoms in symptomatic AD.
引用
收藏
页码:141 / 148
页数:8
相关论文
共 50 条
  • [31] Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum
    Lee, Jongmin
    Jang, Hyemin
    Kang, Sung Hoon
    Kim, Jaeho
    Kim, Ji Sun
    Kim, Jun Pyo
    Kim, Hee Jin
    Seo, Sang Won
    Na, Duk L.
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (44)
  • [32] Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease
    Mila-Aloma, Marta
    Suarez-Calvet, Marc
    Luis Molinuevo, Jose
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2019, 12
  • [33] Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid
    Wiedrick, Jack T.
    Phillips, Jay, I
    Lusardi, Theresa A.
    McFarland, Trevor J.
    Lind, Babett
    Sandau, Ursula S.
    Harrington, Christina A.
    Lapidus, Jodi A.
    Galasko, Douglas R.
    Quinn, Joseph F.
    Saugstad, Julie A.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (03) : 875 - 891
  • [34] Brain Ventricular Volume and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
    Ott, Brian R.
    Cohen, Ronald A.
    Gongvatana, Assawin
    Okonkwo, Ozioma C.
    Johanson, Conrad E.
    Stopa, Edward G.
    Donahue, John E.
    Silverberg, Gerald D.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (02) : 647 - 657
  • [35] Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Families with PSEN1 Mutations
    Fortea, Juan
    Llado, Albert
    Bosch, Beatriz
    Antonell, Anna
    Oliva, Rafael
    Luis Molinuevo, Jose
    Sanchez-Valle, Raquel
    NEURODEGENERATIVE DISEASES, 2011, 8 (04) : 202 - 207
  • [36] White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers
    van Doorn, Linda J. C. van Waalwijk
    Ghafoorian, Mohsen
    van Leijsen, Esther M. C.
    Claassen, Jurgen A. H. R.
    Arighi, Andrea
    Bozzali, Marco
    Cannas, Jorge
    Cavedo, Enrica
    Eusebi, Paolo
    Farotti, Lucia
    Fenoglio, Chiara
    Fortea, Juan
    Frisoni, Giovanni B.
    Galimberti, Daniela
    Greco, Viviana
    Herukka, Sanna-Kaisa
    Liu, Yawu
    Lleo, Alberto
    de Mendonca, Alexandre
    Nobili, Flavio M.
    Parnetti, Lucilla
    Picco, Agnese
    Pikkarainen, Maria
    Salvadori, Nicola
    Scarpini, Elio
    Soininen, Hilkka
    Tarducci, Roberto
    Urbani, Andrea
    Vilaplana, Eduard
    Meulenbroek, Olga
    Platel, Bram
    Verbeek, Marcel M.
    Kuiperij, H. Bea
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 79 (01) : 163 - 175
  • [37] Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers
    Gordon, Brian A.
    Zacks, Jeffrey M.
    Blazey, Tyler
    Benzinger, Tammie L. S.
    Morris, John C.
    Fagan, Anne M.
    Holtzman, David M.
    Balota, David A.
    NEUROBIOLOGY OF AGING, 2015, 36 (05) : 1771 - 1779
  • [38] From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease
    Zetterberg, Henrik
    Blennow, Kaj
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 : S271 - S279
  • [39] Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease
    Eddin, Ahmed Noor
    Hamsho, Khaled
    Adi, Ghaith
    Al-Rimawi, Mohammed
    Alfuwais, Mohammed
    Rab, Saleha Abdul
    Alkattan, Khaled
    Yaqinuddin, Ahmed
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [40] Cerebrospinal fluid biomarkers for pathological processes in Alzheimer's disease
    Rosen, Christoffer
    Zetterberg, Henrik
    CURRENT OPINION IN PSYCHIATRY, 2013, 26 (03) : 276 - 282